PainChek Limited (ASX:PCK)
Australia · Delayed Price · Currency is AUD 0.1700
0.00 (0.00%)
Mar 4, 2026, 3:56 PM AEST
PainChek Revenue
PainChek had revenue of 1.70M AUD in the half year ending June 30, 2025, with 44.64% growth. This brings the company's revenue in the last twelve months to 2.09M, down -52.41% year-over-year. In the fiscal year ending June 30, 2025, PainChek had annual revenue of 3.36M with 25.84% growth.
Revenue (ttm)
2.09M
Revenue Growth
-52.41%
P/S Ratio
16.97
Revenue / Employee
n/a
Employees
n/a
Market Cap
35.53M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 3.36M | 690.49K | 25.84% |
| Jun 30, 2024 | 2.67M | 716.07K | 36.61% |
| Jun 30, 2023 | 1.96M | 961.72K | 96.74% |
| Jun 30, 2022 | 994.15K | 760.26K | 325.05% |
| Jun 30, 2021 | 233.89K | -63.29K | -21.30% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Adheris Health | 40.60M |
| Mach7 Technologies | 29.69M |
| ImExHS | 29.00M |
| Beamtree Holdings | 28.90M |
| Resonance Health | 13.79M |
| PharmX Technologies | 7.65M |
| Vitasora Health | 5.01M |
| Emyria | 2.29M |
PainChek News
- 4 weeks ago - Painchek Ltd (ASX:PCK) (H1 2026) Earnings Call Highlights: Strategic US Expansion and Strong ... - GuruFocus
- 4 weeks ago - Half Year 2026 PainChek Ltd Earnings Call Transcript - GuruFocus